Humanwell Healthcare (600079.SH) has received the drug registration certificate for the lorazepam tablets.

Humanwell Healthcare (600079.SH) announced that its holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate issued by the National Medical Products Administration for its tablet of Mirtazapine Maleate. Mirtazapine Maleate is indicated for sleep disorders, insomnia, especially for those who have difficulty falling asleep, and for preoperative or diagnostic procedures.